|
SFMBT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.020500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.635500E-03 |
| Normal-vs-Stage2 |
6.665700E-02 |
| Normal-vs-Stage3 |
1.284310E-02 |
| Normal-vs-Stage4 |
2.04909999999003E-05 |
| Stage1-vs-Stage2 |
9.030600E-01 |
| Stage1-vs-Stage3 |
6.298800E-01 |
| Stage1-vs-Stage4 |
1.495720E-02 |
| Stage2-vs-Stage3 |
7.921600E-01 |
| Stage2-vs-Stage4 |
1.187040E-01 |
| Stage3-vs-Stage4 |
1.511580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.240700E-03 |
| Normal-vs-AfricanAmerican |
2.260200E-03 |
| Normal-vs-Asian |
1.598170E-02 |
| Caucasian-vs-AfricanAmerican |
5.595400E-01 |
| Caucasian-vs-Asian |
1.884970E-01 |
| AfricanAmerican-vs-Asian |
5.636600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.30149999999041E-05 |
| Normal-vs-Female |
7.593200E-01 |
| Male-vs-Female |
8.836000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.282900E-03 |
| Normal-vs-Extreme_Weight |
3.89450000000124E-05 |
| Normal-vs-Obese |
5.543600E-03 |
| Normal-vs-Extreme_Obese |
1.292240E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.364200E-01 |
| Normal_Weight-vs-Obese |
7.586200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.520000E-01 |
| Extreme_Weight-vs-Obese |
2.963800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.118600E-01 |
| Obese-vs-Extreme_Obese |
6.888400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.339200E-03 |
| Normal-vs-Age(41-60Yrs) |
6.278300E-03 |
| Normal-vs-Age(61-80Yrs) |
7.551000E-04 |
| Normal-vs-Age(81-100Yrs) |
3.882900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.618600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.707800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.919000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.717200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.286000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.613400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.80640000000088E-05 |
| Normal-VS-Type2 PRCC |
8.120600E-03 |
| Normal-VS-KIRP CIMP |
1.909570E-02 |
| Normal-VS-Unclassified PRCC |
4.567000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.348000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.838400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.181210E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.746600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.212800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.274200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.4684000000017E-05 |
| Normal-vs-N1 |
7.236100E-03 |
| Normal-vs-N2 |
1.059550E-02 |
| N0-vs-N1 |
5.980400E-01 |
| N0-vs-N2 |
4.960000E-01 |
| N1-vs-N2 |
4.529800E-01 |
|
|
